Deep Brain Stimulation of the Ventral Anterior Limb of the Internal Capsule for Treatment-Resistant Depression

Autor: Ieke Visser, Peter Notten, Bart de Kwaasteniet, Aart H. Schene, Rick Schuurman, Mariska Mantione, Guus N. Beute, Ferdinand Horst, Henricus G. Ruhé, Mechteld L.C. Hoogendoorn, Isidoor O. Bergfeld, Pepijn van den Munckhof, Jan van Laarhoven, Martijn Figee, Damiaan Denys
Přispěvatelé: ANS - Compulsivity, Impulsivity & Attention, Other departments, Adult Psychiatry, Neurosurgery, Interdisciplinary Centre Psychopathology and Emotion regulation (ICPE), Netherlands Institute for Neuroscience (NIN)
Rok vydání: 2016
Předmět:
Adult
Male
medicine.medical_specialty
Deep brain stimulation
Deep Brain Stimulation
medicine.medical_treatment
CAPSULE/VENTRAL STRIATUM
NUCLEUS-ACCUMBENS
Stress-related disorders Donders Center for Medical Neuroscience [Radboudumc 13]
Placebo
law.invention
Depressive Disorder
Treatment-Resistant

03 medical and health sciences
0302 clinical medicine
Double-Blind Method
Randomized controlled trial
Internal Capsule
law
medicine
Humans
Psychiatry
SCALE
Depression (differential diagnoses)
Netherlands
OUTCOMES
Depressive Disorder
Major

Cross-Over Studies
Intention-to-treat analysis
PATHWAYS
Hamilton Rating Scale for Depression
TRACTOGRAPHY
OBSESSIVE-COMPULSIVE DISORDER
MAJOR DEPRESSION
Middle Aged
medicine.disease
Crossover study
Electrodes
Implanted

Intention to Treat Analysis
030227 psychiatry
Psychiatry and Mental health
Treatment Outcome
Editorial
Anesthesia
REACH
Female
Psychology
Treatment-resistant depression
030217 neurology & neurosurgery
Zdroj: JAMA Psychiatry, 73, 5, pp. 456-64
JAMA Psychiatry, 73, 456-64
JAMA psychiatry, 73(5), 456-464. American Medical Association
Jama psychiatry, 73(5), 456-464. AMER MEDICAL ASSOC
JAMA Psychiatry, 73(5), 456-64. American Medical Association
ISSN: 2168-622X
2168-6238
DOI: 10.1001/jamapsychiatry.2016.0152
Popis: Item does not contain fulltext IMPORTANCE: Patients with treatment-resistant depression (TRD) do not respond sufficiently to several consecutive treatments for major depressive disorder. Deep brain stimulation (DBS) is a promising treatment for these patients, but presently placebo effects cannot be ruled out. OBJECTIVE: To assess the efficacy of DBS of the ventral anterior limb of the internal capsule (vALIC), controlling for placebo effects with active and sham stimulation phases. DESIGN, SETTING, AND PARTICIPANTS: Twenty-five patients with TRD from 2 hospitals in the Netherlands were enrolled between March 22, 2010, and May 8, 2014. Patients first entered a 52-week open-label trial during which they received bilateral implants of 4 contact electrodes followed by optimization of DBS until a stable response was achieved. A randomized, double-blind, 12-week crossover phase was then conducted with patients receiving active treatment followed by sham or vice versa. Response and nonresponse to treatment were determined using intention-to-treat analyses. INTERVENTIONS: Deep brain stimulation targeted to the vALIC. MAIN OUTCOMES AND MEASURES: The change in the investigator-rated score of the 17-item Hamilton Depression Rating Scale (HAM-D-17) was the main outcome used in analysis of the optimization phase. The primary outcome of the crossover phase was the difference in the HAM-D-17 scores between active and sham DBS. The score range of this tool is 0 to 52, with higher scores representing more severe symptoms. Patients were classified as responders to treatment (>/=50% decrease of the HAM-D-17 score compared with baseline) and partial responders (>/=25 but
Databáze: OpenAIRE